Sex Differences in the Clinical Progression of Parkinson's Disease.

QUALITY of life; AGE distribution; COGNITIVE testing; LONGITUDINAL method; PARKINSON'S disease; QUESTIONNAIRES; REGRESSION analysis; SEX distribution; COMORBIDITY; DISEASE progression; POLYPHARMACY; FUNCTIONAL assessment; DESCRIPTIVE statistics

Objective To describe characteristics of Parkinson's disease by sex and determine if differences in disease progression exist. Design Longitudinal, observational study. Setting Twenty-one National Parkinson Foundation Centers of Excellence. Participants People ( N = 4,679; 63% men and 37% women) with idiopathic Parkinson's disease. Methods Demographic and clinical data at enrollment and after 1 year were collected. We defined progression as a 1-year change in the following functional health outcome measures: (a) health-related quality of life (Parkinson's Disease Questionnaire–39), (b) Timed Up and Go test, (c) cognitive function, and (d) number of medications. We compared baseline characteristics between men and women. Then, linear regression models were built to assess the independent contribution of sex to progression. Results At baseline, women were significantly more likely to be older and have greater disease severity and more comorbidities than men despite similar duration of disease. This finding corresponded to worse function as assessed by the Parkinson's Disease Questionnaire–39 and Timed Up and Go test but not to number of medications and cognitive function. After 1 year, declines across all functional measures except delayed recall occurred. No significant changes in Parkinson's Disease Questionnaire–39, Timed Up and Go, number of medications, or verbal fluency between men and women occurred. Women had a more significant improvement in delayed recall than men. Conclusion Numerous small baseline differences occurred between men and women with PD, although differences in markers of progression were few. Findings suggest that clinical manifestations and prognosis appear similar by sex under the same treatment conditions. [ABSTRACT FROM AUTHOR]

Copyright of JOGNN: Journal of Obstetric, Gynecologic & Neonatal Nursing is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)